The GRACE ACS risk calculator estimates risk of death following acute coronary syndrome (ACS)
The GRACE 2.0 ACS Risk Calculator implements the revised GRACE algorithms for predicting death or death/myocardial infarction following an initial acute coronary syndrome (ACS).
GRACE (the Global Registry of Acute Coronary Events) is an international observational programme of outcomes for patients who were hospitalized with an ACS in the 10 years from 1999. GRACE includes nearly 250 hospitals in 30 countries, and enrolled a total of 102,341 patients. Participating physicians receive confidential quarterly reports showing their outcomes side by side with the aggregate outcomes of all participating hospitals. The GRACE Risk Score has been extensively validated prospectively and externally.
Variables measured include age, heart rate, systolic blood pressure, renal function, congestive heart failure, ST-segment deviation, cardiac arrest and elevated biomarkers, which together provide more than 90% of the accuracy of the complete multivariable prediction model.
Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, Avezum A,Goodman SG, Flather MD, Anderson FA Jr, Granger CB.
Elbarouni B, Goodman SG, et al.
The GRACE 2.0 ACS Risk Calculator implements the revised GRACE algorithms for predicting death or death/myocardial infarction following an initial acute coronary syndrome (ACS).
GRACE (the Global Registry of Acute Coronary Events) is an international observational programme of outcomes for patients who were hospitalized with an ACS in the 10 years from 1999. GRACE includes nearly 250 hospitals in 30 countries, and enrolled a total of 102,341 patients. Participating physicians receive confidential quarterly reports showing their outcomes side by side with the aggregate outcomes of all participating hospitals. The GRACE Risk Score has been extensively validated prospectively and externally.
Variables measured include age, heart rate, systolic blood pressure, renal function, congestive heart failure, ST-segment deviation, cardiac arrest and elevated biomarkers, which together provide more than 90% of the accuracy of the complete multivariable prediction model.
Fox KA, Dabbous OH, Goldberg RJ, Pieper KS, Eagle KA, Van de Werf F, Avezum A,Goodman SG, Flather MD, Anderson FA Jr, Granger CB.
Elbarouni B, Goodman SG, et al.
© 2020 QxMD Software Inc., all rights reserved. No part of this service may be reproduced in any way without express written consent of QxMD. This information should not be used for the diagnosis or treatment of any health problem or disease. This information is not intended to replace clinical judgment or guide individual patient care in any manner. Click here for full notice and disclaimer.